Groupe PureTech Health plc

Action

Marché Fermé - London S.E. Autres places de cotation 17:35:20 06/08/2026			Varia. 5j.	Varia. 1 janv.
116,60 ^GBX	+0,52%		-2,51%	-6,72%

13/07	PureTech Health annonce l'administration du traitement au premier patient de l'essai de phase 3 de Celea	AN
13/07	PureTech Health : Celea Therapeutics lance un essai de phase finale pour son traitement de la fibrose pulmonaire idiopathique	MT

Société	Dirigeant
Puretech Health LLC Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements.	Daphne Zohar